The global allergy medicine market is anticipated to grow at a significant CAGR during the forecast period. Allergy medicine supports to block a certain natural substance such as histamine that the body makes during an allergic reaction. It works by drying allergic symptoms such as watery eyes and a runny nose by blocking another natural substance made by the body such as acetylcholine. The major factor for the growth of the market during the forecast period is the increasing prevalence of various types of allergies.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/allergy-medicine-market
Moreover, the market is also growing due to the new product launches. For instance, in March 2018, Dr Reddy’s Laboratories launched an ant- allergic drug, levocetirizine dihydrochloride, in tablet form in the US market. It is an over-the-counter therapeutic equivalent generic version of UCB’s Xyzal allergy tablets for treating and relieving allergies. Additionally, in January 2020, Aimmune Therapeutics received approval for Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] from the US FDA. It is used for the treatment of peanut allergy in children.
Some major players in the market include Johnson & Johnson Services, Inc., Sanofi SA, and GlaxoSmithKline plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Cadila Pharmaceuticals Ltd. announced the launch of Bilastine syrup (30 ml) and Bilastine tablets in the strength of 20mg. It is an antihistamine drug used in the treatment of allergic rhinitis.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Distribution Channel
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Johnson & Johnson Services, Inc., Sanofi SA, and GlaxoSmithKline plc, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Allergy Medicine Market Report by Segment
By Type
- Eye Allergy
- Rhinitis
- Asthma
- Skin Allergy
- Food Allergy
- Other
By Distribution Channel
- Retail Pharmacy
- Online Pharmacy
- Others
A full report of Allergy Medicine Market is available at: https://www.omrglobal.com/industry-reports/allergy-medicine-market
Allergy Medicine Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Johnson & Johnson Services, Inc.
- Sanofi SA
- GlaxoSmithKline plc
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
